Grimmler M - Search Results

1

PLAC1 is essential for FGF7/FGFRIIIb-induced Akt-mediated cancer cell proliferation.

Roldán DB, Grimmler M, Hartmann C, Hubich-Rau S, Beißert T, Paret C, Cagna G, Rohde C, Wöll S, Koslowski M, Türeci Ö, Sahin U. Roldán DB, et al. Among authors: grimmler m. Oncotarget. 2020 May 19;11(20):1862-1875. doi: 10.18632/oncotarget.27582. eCollection 2020 May 19. Oncotarget. 2020. PMID: 32499871 Free PMC article.

2

Comment to: Extensive analytical evaluation of the performances of the new DiaSys PCT assay and comparison with Elecsys B·R·A·H·M·S PCT test on Roche Cobas and B·R·A·H·M·S PCT-sensitive Kryptor.

Masetto T, Grimmler M. Masetto T, et al. Among authors: grimmler m. Clin Chem Lab Med. 2023 Sep 26;62(2):e48-e50. doi: 10.1515/cclm-2023-0997. Print 2024 Jan 26. Clin Chem Lab Med. 2023. PMID: 37746855 Free article. No abstract available.

3

Immunoaffinity LC-MS/MS Quantification of the Sepsis Biomarker Procalcitonin Using Magnetic- and Polystyrene-Bead Immobilized Polyclonal Antibodies.

Tölke SA, Masetto T, Reuschel T, Grimmler M, Bindila L, Schneider K. Tölke SA, et al. Among authors: grimmler m. J Proteome Res. 2023 Oct 6;22(10):3135-3148. doi: 10.1021/acs.jproteome.3c00082. Epub 2023 Sep 6. J Proteome Res. 2023. PMID: 37672672

4

Bioinformatical Design and Performance Evaluation of a Nucleocapsid- and an RBD-Based Particle Enhanced Turbidimetric Immunoassay (PETIA) to Quantify the Wild Type and Variants of Concern-Derived Immunoreactivity of SARS-CoV-2.

Wey L, Masetto T, Spaeth A, Brehm J, Kochem C, Reinhart M, Müller H, Kempin U, Lorenz F, Peter C, Grimmler M. Wey L, et al. Among authors: grimmler m. Biomedicines. 2023 Jan 8;11(1):160. doi: 10.3390/biomedicines11010160. Biomedicines. 2023. PMID: 36672668 Free PMC article.

5

Vaccine-induced SARS-CoV-2 antibody response: the comparability of S1-specific binding assays depends on epitope and isotype discrimination.

Schest S, Langer C, Stiegler Y, Karnuth B, Arends J, Stiegler H, Masetto T, Peter C, Grimmler M. Schest S, et al. Among authors: grimmler m. Front Immunol. 2023 Oct 26;14:1257265. doi: 10.3389/fimmu.2023.1257265. eCollection 2023. Front Immunol. 2023. PMID: 37965324 Free PMC article.

6

The Impact of p70S6 Kinase-Dependent Phosphorylation of Gemin2 in UsnRNP Biogenesis.

Esser LM, Li Q, Jüdt M, Kähne T, Stork B, Grimmler M, Wesselborg S, Peter C. Esser LM, et al. Among authors: grimmler m. Int J Mol Sci. 2023 Oct 25;24(21):15552. doi: 10.3390/ijms242115552. Int J Mol Sci. 2023. PMID: 37958537 Free PMC article.

7

Comprehensive Comparison of the Capacity of Functionalized Sepharose, Magnetic Core, and Polystyrene Nanoparticles to Immuno-Precipitate Procalcitonin from Human Material for the Subsequent Quantification by LC-MS/MS.

Masetto T, Matzenbach K, Reuschel T, Tölke SA, Schneider K, Esser LM, Reinhart M, Bindila L, Peter C, Grimmler M. Masetto T, et al. Among authors: grimmler m. Int J Mol Sci. 2023 Jun 30;24(13):10963. doi: 10.3390/ijms241310963. Int J Mol Sci. 2023. PMID: 37446139 Free PMC article.

8

Phosphorylation of pICln by the autophagy activating kinase ULK1 regulates snRNP biogenesis and splice activity of the cell.

Esser LM, Schmitz K, Hillebrand F, Erkelenz S, Schaal H, Stork B, Grimmler M, Wesselborg S, Peter C. Esser LM, et al. Among authors: grimmler m. Comput Struct Biotechnol J. 2023 Mar 16;21:2100-2109. doi: 10.1016/j.csbj.2023.03.015. eCollection 2023. Comput Struct Biotechnol J. 2023. PMID: 36968021 Free PMC article.

9

Commutability Assessment of Candidate Reference Materials for Lipoprotein(a) by Comparison of a MS-based Candidate Reference Measurement Procedure with Immunoassays.

Dikaios I, Althaus H, Angles-Cano E, Ceglarek U, Coassin S, Cobbaert CM, Delatour V, Dieplinger B, Grimmler M, Hoofnagle AN, Kostner GM, Kronenberg F, Kuklenyik Z, Lyle AN, Prinzing U, Ruhaak LR, Scharnagl H, Vesper HW, Deprez L. Dikaios I, et al. Among authors: grimmler m. Clin Chem. 2023 Mar 1;69(3):262-272. doi: 10.1093/clinchem/hvac203. Clin Chem. 2023. PMID: 36644921

10

SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients - a comparative long term post-infection study.

Brehm J, Spaeth A, Dreßler L, Masetto T, Dannenberg R, Peter C, Grimmler M. Brehm J, et al. Among authors: grimmler m. Front Immunol. 2022 Aug 17;13:915338. doi: 10.3389/fimmu.2022.915338. eCollection 2022. Front Immunol. 2022. PMID: 36059441 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page